Literature DB >> 28230044

A meta-analysis to evaluate the diagnostic value of dual-time-point F-fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of pulmonary nodules.

Ming Zhao1, Yongfu Ma1, Bo Yang1, Yuqi Wang1.   

Abstract

OBJECTIVES: This meta-analysis aimed at evaluating the efficacy of dual-time-point (DTP) F-fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography (PET/CT) in diagnosing pulmonary nodules.
METHODS: Using computer and manual search, the current research about the efficacy of DTP F-FDG PET/CT in diagnosing pulmonary nodules was collected. According to the evaluation criteria of Quality Assessment of Diagnostic Accuracy Studies Scale, the data from 13 studies were analyzed by Meta-DiSc software, and the sensitivity (Sen), specificity (Spe), diagnostic odds ratios (DOR), positive likelihood ratios (LR+), and negative likelihood ratios (LR-) were summarized.
RESULTS: A total of 13 articles were included in this study, involving 962 patients. The meta-analysis showed that the rough Sen of DTP PET/CT was 0.80 (95% confidence interval [CI] 0.76-0.84, I2 = 83.2%), the summary Spe was 0.75 (95% CI 0.71-0.79, I2 = 89.3%), the summary LR + and LR- were 2.57 (95% CI 1.54-4.29) and 0.28 (95% CI 0.16-0.5), respectively, and DOR was 10.01 (95% CI 3.83-26.18).
CONCLUSION: DTP F-FDG PET/CT has similar Sen and Spe, with single-time-point PET/CT in diagnosing pulmonary nodules. Further high-quality research is required to explore the potential value of DTP F-FDG PET/CT.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28230044     DOI: 10.4103/0973-1482.200742

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  4 in total

1.  Diagnostic performance of fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a meta-analysis.

Authors:  Duilio Divisi; Mirko Barone; Luca Bertolaccini; Gino Zaccagna; Francesca Gabriele; Roberto Crisci
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 2.  Diagnostic Performance of PET or PET/CT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours according to Published Meta-Analyses.

Authors:  Filippo Lococo; Barbara Muoio; Marco Chiappetta; Dania Nachira; Leonardo Petracca Ciavarella; Stefano Margaritora; Giorgio Treglia
Journal:  Contrast Media Mol Imaging       Date:  2020-04-25       Impact factor: 3.161

3.  Different Prognostic Values of Dual-Time-Point FDG PET/CT Imaging Features According to Treatment Modality in Patients with Non-Small Cell Lung Cancer.

Authors:  Su Jin Jang; Jeong Won Lee; Ji-Hyun Lee; In Young Jo; Sang Mi Lee
Journal:  Tomography       Date:  2022-04-08

4.  Clinical Impact of Dual Time Point 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging in Pancreatic Cancer.

Authors:  Takahiro Einama; Yoji Yamagishi; Yasuhiro Takihata; Fukumi Konno; Kazuki Kobayashi; Naoto Yonamine; Ibuki Fujinuma; Takazumi Tsunenari; Keita Kouzu; Akiko Nakazawa; Toshimitsu Iwasaki; Eiji Shinto; Jiro Ishida; Hideki Ueno; Yoji Kishi
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.